C1GALT1 and gastric cancer: Both in vivo and in vitro experiments showed that C1GALT1 promotes EPHA2 phosphorylation and Ephrin A1-mediated cell migration by regulating the O-glycosylation of EPHA2, suggesting that C1GALT1 may be a potential therapeutic target for gastric cancer [100].